![[LSUK] Life-Sciences-UK.com - The UK Life Sciences Web Portal](/images/basics/lsuk-life-sciences-uk-portal-logo.svg){kind=logo}
Advertisement
All
>
Persons > United Kingdom (GB)
Please find below persons from the United Kingdom (GB) or related to British organisations.Total search results: 2831 | Ordered by Region (ascending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 
  Person |
Position |
Organisation (Group) |
 Region |
|---|---|---|---|
| Koutsos, Anastasios (College Hill 201108 College Hill Life Sciences) | Public Relations Manager / Investor Relations Manager | Instinctif Partners (Group) | Greater London (region) |
| Kozlov, Andrew (4BIO Capital 202305) | n. a. | 4BIO Ventures (4BIO Capital) (Group) | Greater London (region) |
| Kristiansen, Kjell (Microtest Diagnostics 201206– Managing Director before Phadia AB) | Managing Director | Microtest Diagnostics Ltd. | Greater London (region) |
| Kruize, Niels (LGC 201108 Sales Director LGC Genomics) | Sales Manager / Marketing Manager | LGC (Group) | Greater London (region) |
| Kuzmin, Dmitry (Dima) (4BIO Ventures 2019 Managing Partner) | Managing Partner (investment firm) | 4BIO Ventures (4BIO Capital) (Group) | Greater London (region) |
| Laing, Adam (Melio Health 202401 CEO + Co-Founder of IMU Biosciences) | Chief Executive Officer (CEO) | Melio Healh (Group) (IMU Biosciences) | Greater London (region) |
| Lam, Kris (Consilium Strategic Communications 202305) | Public Relations Manager / Investor Relations Manager | ICR (Group) | Greater London (region) |
| Lane, Andrew (Unilever Ventures 200605 Director) | n. a. | Unilever (Group) | Greater London (region) |
| Lane, Anne (Univ College London 202008 CEO of UCL Business) | Chief Executive Officer (CEO) | University College London (UCL) | Greater London (region) |
| Lapierre, Didier (GlaxoSmithKline 200804 VP Clinical Develop Infectious Diseases) | Clinical Research Manager | GSK (Group) | Greater London (region) |
| Larkin, Ken (Univ London 201301 CEO of London BioScience Innovation Centre) | Chief Executive Officer (CEO) | University of London | Greater London (region) |
| Lasagni, Giulia (Instinctif Partners 202305) | Public Relations Manager / Investor Relations Manager | Instinctif Partners (Group) | Greater London (region) |
| Law, Nigel (LGC 200601 CEO) | Chief Executive Officer (CEO) | LGC (Group) | Greater London (region) |
| Learmonth, Pamela (BIA 201708 Director Public Affairs + Communications) | Public Relations Manager / Investor Relations Manager | BioIndustry Association (BIA) (GB) | Greater London (region) |
| Leathers, David | n. a. | Carlyle (Group) | Greater London (region) |
| Leaver, Tim (Delphic Europe Diagnostics 200310 Managing Director) | Managing Director | Delphic Europe Diagnostics Ltd. | Greater London (region) |
| Leck, Renee (Orchard Therapeutics 201901 Corporate + Investor Contact) | Public Relations Manager / Investor Relations Manager | Orchard Therapeutics (Group) | Greater London (region) |
| Lee, Melanie (LifeArc 201811– CEO before BTG plc + NightstaRx + Think 10 + Syntaxin + UCB + Celltech + GSK) | Chief Executive Officer (CEO) | LifeArc (GB) | Greater London (region) |
| Leech, Alex (Alchemab Therapeutics 202010 Founding CEO + Partner at SV Health Investors) | Chief Executive Officer (CEO) | Alchemab Therapeutics Ltd. | Greater London (region) |
| Leigh, Ian (Greenwood Way Capital 201906 Founder) | Investment Manager | Greenwood Way Capital (GB) | Greater London (region) |
| Lemoine, Adrien (Orchard Therapeutics 202001 CBO before AstraZeneca) | Chief Business Officer (CBO) | Orchard Therapeutics (Group) | Greater London (region) |
| Lempidaki, Stella (Optimum Communications 202201) | Public Relations Manager / Investor Relations Manager | Optimum Strategic Communications | Greater London (region) |
| Lench, Nick (London Genetics 200806 CEO) | Chief Executive Officer (CEO) | London Genetics Ltd. | Greater London (region) |
| Lepore, John (GSK 201106 VP + General Manager Biologicals + Corporate GSK China) | General Manager (management) | GSK (Group) | Greater London (region) |
| Levy-Yurista, Guy (Synthace 202105– CEO before Sisense + MicroStrategy + McAfee + AOL) | Chief Executive Officer (CEO) | Synthace (Group) | Greater London (region) |
| Lewis, Mathew R. (Imperial College London 201806 COO at MRC-NIHR National Phenome Center) | Chief Operating Officer (COO) | Imperial College London | Greater London (region) |
| Lewis, Richard (Downing Ventures 201809 Investment Director) | Investment Manager | Downing (Group) | Greater London (region) |
| Leyendecker, Ludwig (Freshfields Bruckhaus Deringer 201610) | Attorney / Lawyer | Freshfields (Group) | Greater London (region) |
| Lightfoot, Andrew (Peptinnovate Ltd 201506 CEO) | Chief Executive Officer (CEO) | Immune Regulation (Group) | Greater London (region) |
| Linacre, Simon (Holtzbrinck 202306 Head of Content, Brand + Press at Digital Science) | Public Relations Manager / Investor Relations Manager | Holtzbrinck (Group) | Greater London (region) |
| Linden, Michael (Univ College London 201411 Professor + Director of UCL Gene Therapy Consortium + Pfizer 201412–) | Professor | University College London (UCL) | Greater London (region) |
| Linding, Rune (Institute of Cancer Research 200907 Head Cellular and Molecular Logic Team) | Researcher (university / research institute) | University of London | Greater London (region) |
| Lisle, John (Inpharmatica 200501 CEO) | Chief Executive Officer (CEO) | Galapagos (Group) | Greater London (region) |
| Lisziewicz, Julianna (Treos Bio 201606 CSO + Co-Founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Treos Bio (Group) | Greater London (region) |
| Lloyd-Harris, Genghis (Abingworth 201402 Partner) | Partner (venture partner) | Carlyle (Group) | Greater London (region) |
| Loudon, Adam (Instinctif Partners 202304) | Public Relations Manager / Investor Relations Manager | Instinctif Partners (Group) | Greater London (region) |
| Louv, Bill (GSK 200611– Senior VP Information Technoloy) | n. a. | GSK (Group) | Greater London (region) |
| Luque, Brian (Nightstar Therapeutics 201809 Senior Manager IR) | Public Relations Manager / Investor Relations Manager | Biogen (Group) | Greater London (region) |
| Lynch, Thomas (Amarin 200805 Chaiman + CEO) | Chief Executive Officer (CEO) | Amarin Corporation plc (Nasdaq: AMRN) | Greater London (region) |
| Macfarlane, Bruce (MMC Ventures 201912 Managing Partner) | Managing Partner (investment firm) | MMC Ventures | Greater London (region) |
| Mackie, Andrew (IP2IPO 200601 Head Life Sciences) | n. a. | IP Group (Group) | Greater London (region) |
| Mackin, Brent (Intertek 200901 VP Laboratory Services) | Product Manager (personnel) | Intertek (Group) | Greater London (region) |
| MacLauchlan, Lucy (Inizio 202206 Global Head of Marketing) | Sales Manager / Marketing Manager | Inizio (Group) | Greater London (region) |
| Madeira do Ó, Nuno (Bastion Therapeutics 202309 CEO + Co-Founder) | Chief Executive Officer (CEO) | Bastion Therapeutics Ltd. | Greater London (region) |
| Madhok, Anuj (TopiVert 201908 CBO) | Chief Business Officer (CBO) | TopiVert Pharma Ltd. | Greater London (region) |
| Maher, John (Leucid Bio 202110 CSO + Co-Founder + at King’s College London) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Leucid Bio (GB) | Greater London (region) |
| Maini, Tidu (Imperial College 200508 + InforSense BoD 200508–) | n. a. | Imperial College London | Greater London (region) |
| Makin, Louise (BTG 200704 CEO) | Chief Executive Officer (CEO) | BTG (Group) | Greater London (region) |
| Malhotra, Rajat (Wren Capital 202107 Managing Partner) | Managing Partner (investment firm) | Wren Capital LLP | Greater London (region) |
| Malik, Shahzad (Advent Venture Partners 201402 General Partner) | General Partner (venture partner) | Advent Venture Partners (Advent Ltd.) | Greater London (region) |
| Manser, Olivia (Autolus 202402 Investor Relations before Consilium Strategic Communications 2018H1– before Stifel) | Public Relations Manager / Investor Relations Manager | Autolus Therapeutics plc (Nasdaq: AUTL) | Greater London (region) |
| Marchington, Allan (Intermediate Capital Group 202403 Managing Director, Head of Life Sciences) | Managing Director | Intermediate Capital Group (ICG) (LSE: ICP) | Greater London (region) |
| Margo, Fay (Brackendale Consulting 201807 CEO + Founder) | Chief Executive Officer (CEO) | Brackendale Consulting | Greater London (region) |
| Mariggi, Giovanni (Medicxi 202208 Partner) | Partner (venture partner) | Medicxi Ventures (formerly Index Ventures Life Sciences) | Greater London (region) |
| Markova, Nelly (Molten Ventures 202302 Principal) | Principal (venture capital) | Molten Ventures (Group) | Greater London (region) |
| Marriage, Phillip (Phil) (Instinctif Partners 202101) | Public Relations Manager / Investor Relations Manager | Instinctif Partners (Group) | Greater London (region) |
| Marron, Damian (Agalimmune 201603 CEO before TxCell + Cytheris + Trophos + NiCox + 3M + Orphan Europe) | Chief Executive Officer (CEO) | BioLineRx (Group) | Greater London (region) |
| Marshall, Kirianne (Open Pharma Research 201907 Managing Director + Co-Founder before IIR + IBC) | Managing Director | Open Pharma Research Ltd. | Greater London (region) |
| Martin, Stephen (GSK 201307 Head of Biopharmaceuticals Discovery) | Research & Development Manager | GSK (Group) | Greater London (region) |
| Martinez-Davis, Maya (GSK 202001– President of GSK US Pharma joined 9/19 before Merck (DE) + Pfizer) | President/Director/Head Business Group/Unit/Division | GSK (Group) | Greater London (region) |
| Masterson, Phil (Cancer Researh UK 202009 Head of New Ventures team) | cancer | Cancer Research UK (CRUK) (Group) | Greater London (region) |
| Mateus, Manel (Optimum Strategic Communications 201902) | Public Relations Manager / Investor Relations Manager | Optimum Strategic Communications | Greater London (region) |
| Mathur, Supriya (Optimum Strategic Communications 201905 before Hume Brophy) | Public Relations Manager / Investor Relations Manager | Optimum Strategic Communications | Greater London (region) |
| Matthews, Nicholas (Nick) (Informa 202004 Informa Connect) | n. a. | Informa (Group) [NEW] | Greater London (region) |
| Mayr, Manuel (King’s College London 200801) | Professor | University of London | Greater London (region) |
| Mazza, Giuseppe (Engitix 201901 CEO + Co-Founder before Promethera Biosciences) | Chief Executive Officer (CEO) | Engitix (Group) | Greater London (region) |
| McCarthy, Christine (Alacrita 201504– Associate Partner before Sanofi) | Consultant (economic/technology) | Alacrita (Group) | Greater London (region) |
| McCooke, Nick (DNA Electronics 201406– CBO beforeOxford Cancer Biomarkers + Pronota + Solexa) | Chief Business Officer (CBO) | DNA Electronics (DNAe) (Group) | Greater London (region) |
| McCreadie, Jessica (Legal & General 202011 Investment Director of Health + Care at Legal & Genereal Retail Retirement) | Investment Manager | Legal & General (Group) | Greater London (region) |
| McGill, Iain (Quell Therapeutics 2021 CEO) | Chief Executive Officer (CEO) | Quell Therapeutics Ltd. (QuellTX) | Greater London (region) |
| McGowan, Peter (Prokarium 201912– CFO) | Chief Financial Officer (CFO) | Prokarium Ltd. | Greater London (region) |
| McGrath, Sophie (Goodwin Procter 201811– Partner European Life Sciences practice) | consulting (economic) | Goodwin Procter (Goowin Law) (Group) | Greater London (region) |
| McKeown, Denise (St. George’s Hospital London 201007 Toxicology RnD) | Chief Medical Officer (CMO) | St. George’s, University of London | Greater London (region) |
| McKernan, Ruth (SV Health Investors 202310 Venture Partner formerly CEO of Innovate UK) | Chief Executive Officer (CEO) | SV Health Investors (Group) | Greater London (region) |
| McKinley, Geoffrey A. (Osmetech 200612 VP Business Development) | Business Development Manager / Strategy Manager | Roche (Group) | Greater London (region) |
| McLaren, John (Dinaqor 202009– Chairman of Dynacor Ltd former British diplomat, investment banker + venture capitalist) | Board member | Dinaqor (Group) | Greater London (region) |
| McLintock, Sean (Neo Kuma Ventures 202107 Partner) | Partner (venture partner) | Neo Kuma Venutures (GB) | Greater London (region) |
| McManus, Paul (Walbrook PR 2009– Founder) | Public Relations Manager / Investor Relations Manager | Walbrook PR Ltd. | Greater London (region) |
| Mehta, Raj (GammaDelta Therapeutics 201705– Director IP + Alliance Management + Bus Dev before Interim CEO + CRT) | IP Manager | Takeda (Group) | Greater London (region) |
| Melcher, Michaela (World Trade Group LEFT SUMMER 2013) | Sales Manager / Marketing Manager | World Trade Group Ltd. (WTG) | Greater London (region) |
| Meyenburg, Jason (Orchard Therapeutics 201803– CCO before Sucampo Pharmaceuticals + Vtesse + Alexion) | Chief Commercial Officer (CCO) | Orchard Therapeutics (Group) | Greater London (region) |
| Michael, Adam (Northbank Communications 200702 Acoount Director) | n. a. | Instinctif Partners (Group) | Greater London (region) |
| Milligan, Ivar (Consilium 201705) | Public Relations Manager / Investor Relations Manager | ICR (Group) | Greater London (region) |
| Milsom, Sarah (Touchlight Genetics 201606 Business Development Manager) | Chief Operating Officer (COO) | Eyebiotech Ltd. (EyeBio) | Greater London (region) |
| Mir, Sohaib (LifeArc Ventures 202302 Senior Investment Principal before ALSA Ventures + CIC) | Principal (venture capital) | LifeArc (GB) | Greater London (region) |
| Mistry, Ajay (PolyTherics 201201 Business Development Manager) | Business Development Manager / Strategy Manager | Abzena (Group) | Greater London (region) |
| Mitchell, Michelle (Cancer Research UK 202207 CEO) | Chief Executive Officer (CEO) | Cancer Research UK (CRUK) (Group) | Greater London (region) |
| Montero-MacColl, James (EasyFairs 202302 Senior Marketing Manager at EasyFairs UK) | Sales Manager / Marketing Manager | Artexis (Group) | Greater London (region) |
| Morgan, Janet (LifeArc 202009 Head of Corporate Affairs) | n. a. | LifeArc (GB) | Greater London (region) |
| Morony, Mike (Quaero Capital 201508– Business Development London before Gerson Lehrman + Nomura Intl) | n. a. | Quaero Capital (Group) | Greater London (region) |
| Mortazavi, Ali (Silence Therapeutics 201305– CEO before Director of Corporate Strategy joined 2012) | Corporate Strategy Manager | Silence Therapeutics (Group) | Greater London (region) |
| Mount, Natalie (Adaptate Biotherapeutics 201910– CEO before GammaDelta Tx + Cell + Gene Therapy Catapult + Pfizer) | Chief Executive Officer (CEO) | Takeda (Group) | Greater London (region) |
| Moussavi, Artin (Leucid Bio 202110 CEO formerly TC BioPharm 201708 CBO) | Chief Business Officer (CBO) | Leucid Bio (GB) | Greater London (region) |
| Muir, Andrew (Future Planet Capital 202404 INvestment Director before Midven 202004 UKI2S) | Investment Manager | Future Planet Capital (Group) | Greater London (region) |
| Mulier, Pieter (Mulier Capital 200506) | n. a. | Mulier Capital Ltd. | Greater London (region) |
| Mulvany, Kenneth (Proximagen 201111 CEO) | Chief Executive Officer (CEO) | Proximagen (Group) | Greater London (region) |
| Muralidhar, Bali (Abingworth 202109 Managing Partner before MVM Life Science Partners 201404 Partner) | Partner (venture partner) | Carlyle (Group) | Greater London (region) |
| Murphy, Katherine (Consilium Strategic Communications 201711– Executive Consultant) | Public Relations Manager / Investor Relations Manager | ICR (Group) | Greater London (region) |
| Murphy, Martin (Syncona CEO before Wellcome Trust Sigma project + MVM Life Science Partners + 3i + McKinsey) | Chief Executive Officer (CEO) | Syncona (Group) | Greater London (region) |
| Musisi, Hannah (Coulter Partners 202210– Executive Director before own consultancy + Bloomberg + KPMG) | Human Resources Manager | Coulter Partners (The Coulter Partnership Ltd.) | Greater London (region) |
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
